+ Filter



IGRP

Anti-IGRP ProductsBackground
Anti-IGRP Products
- Mouse Anti-IGRP Recombinant Soluble TCR (clone A14) (scTCR-0543YC-S(P))
-
- Epitope: KYNKANAFL
- MHC: H2-Kᵈ
-
- Epitope: KYNKANAFL
- MHC: H2-Kᵈ
- Recombinant Mouse Anti-IGRP Soluble TCR (C-Cys) (VS-0622-YF4552) (VS-0622-YF4552)
-
- Epitope: KYNKANAFL
- MHC: H2-Kᵈ
- Recombinant Mouse Anti-IGRP Soluble TCR (KIH) (VS-0622-YF7260) (VS-0622-YF7260)
-
- Epitope: KYNKANAFL
- MHC: H2-Kᵈ
View More Products
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
More Infomation
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Background
Type 1 diabetes (T1D) in both humans and nonobese diabetic (NOD) mice is a chronic autoimmune disease that results from destruction of pancreatic β cells by CD4+ and CD8+ T cells targeting many antigens. A large fraction of the islet-associated CD8+ cells in NOD mice recognize the mimotopes NRP-A7 and -V7 in the context of the MHC molecule Kd. These T cells are diabetogenic, target a peptide from islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP 206-214, similar to NRP-A7 and -V7), and circulate in the blood, particularly as clinical disease nears. Another important feature of the diabetogenic CD8+ response is that it involves recognition, by smaller T cell pools, of many other IGRP epitopes and epitopes in other, even ubiquitous, autoantigens, such as dystrophia myotonica kinase (DMK). The polyspecificity of this T cell response is compounded by the fact that individual specificities harbor clones engaging pMHC over a range of avidities, the strength of which correlates with pathogenic potential.